StockNews.AI
UTHR
StockNews.AI
174 days

United Therapeutics Corporation Reports Fourth Quarter and Full Year 2024 Financial Results

1. UTHR reported record revenues of $2.88 billion for 2024. 2. Revenue growth of 24% compared to 2023 highlights strong performance.

2m saved
Insight
Article

FAQ

Why Bullish?

Strong revenue growth indicates positive company performance, likely to attract investors. Historically, similar revenue announcements have resulted in price upticks for UTHR.

How important is it?

The financial results are critical for assessing UTHR's growth potential, significantly impacting investor sentiment and stock valuation.

Why Long Term?

Sustained revenue growth signals potential for ongoing success and investor confidence. It can lead to further investment and expansion opportunities over time.

Related Companies

VRTXAMGNREGN
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced its financial results for the quarter and year ended December 31, 2024. Full year 2024 revenues rose to a record $2.88 billion, reflecting 24% growth over 2023. “I want to congratulate every Unitherian for their relentless dedication, which has allowed us to deliver a third consecutive year of record revenue,” said Martine Rothblatt, P.

Related News